Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caredx Inc (NQ: CDNA )

23.13 +0.55 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Caredx Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
CareDx, Inc (CDNA) Q3 2021 Earnings Call Transcript
CDNA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CareDx: Q3 Earnings Insights
CareDx (NASDAQ:CDNA) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings CareDx... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
Via Benzinga
CareDx Inc (CDNA) & Pinterest Inc (PINS) Technical Analysis
As expected PINS is starting to resume lower. 
Via Talk Markets
CareDx & Intellia Therapeutics Elliott Wave Analysis
At this point the flat correction into wave (4) could be completed, if not we are just missing one last leg down. 
Via Talk Markets
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
Which subset of the COVID-19 healthcare market will outperform over the next year? 
Via The Motley Fool
Exposures COVID-19
Elliott Wave Analysis: AVAV, CDNA, ESLT, HUBS, NIO And TDOC
Technical Analysis: AeroVironment Inc (AVAV), CareDx Inc (CDNA), Elbit Systems Inc (ESLT), Hubspot Inc (HUBS), Nio Inc (NIO) and Teladoc Health Inc (TDOC). 
Via Talk Markets
CareDx, inc (CDNA) Q2 2021 Earnings Call Transcript
CDNA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
Exposures Product Safety
Elliott Wave Technical Analysis For Six US Stocks - CDNA, CRWD, FATE, UPS, HDB, SPOT
CareDx, CrowdStrike, Fate Therapeutics, HDFC Bank, Spotify, ​​​​​​​UPS - Daily charts. 
Via Talk Markets
IPO Preview: Full Truck Alliance, Sprinklr, Mister Car Wash, Soulgate Lead Busy Week Of 10+ Offerings
The week of June 21 is setting up to be one of the busiest IPO weeks in some time with more than dozen companies that could go public with listings. Here is a look at some of the... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Medical Device Maker Quanterix Stock Shows Rising Relative Strength
On Friday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating upgrading to 91 from 88 a day before. 
Via Investor's Business Daily
Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com
Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021
Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had... 
Via Benzinga
This Under-the-Radar Healthcare Company Quietly Surged During the Pandemic
CareDx just posted 76% year-over-year revenue growth for the first quarter and raised its 2021 guidance. 
Via The Motley Fool
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics... 
Via Benzinga
CareDx Inc (CDNA) Q1 2021 Earnings Call Transcript
CDNA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ: 
Via Benzinga
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple... 
Via Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.